Coronavirus research tools: Cayman Chemical
Identifying drugs and developing rapid and accurate diagnostic tests for SARS-CoV-2 are currently at the…
Browsing: Disease Diagnosis
A COVID-19 machine learning model based on standard laboratory tests – an interview with Steven Phelps and Vafa Bayat of Bitscopic
In an interview with leaders from Bitscopic, we learn about the predictive model, with a machine learning algorithm that they use to predict the diagnostic fingerprint of COVID-19, using standard laboratory tests.
A peek behind the paper – Mohammad K Parvez on coronaviral hepatitis
In an exclusive interview with an author behind one of the papers published in the recent Future Virology Special Focus Issue, heptatitis and COVID-19 are discussed.
Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection
In this Special Report from the ‘COVID-19: studying the global pandemic’ Special Focus Issue authors theorize about the identification of asymptomatic patients and the impact this has on the spread of COVID-19.
The importance of diagnostic testing for COVID-19
As the coronavirus surges across the globe, diagnostic testing comes into its own, as researchers unite to confront, delay and stop its spread. In the absence of either proven effective therapy or a vaccine, diagnostic testing becomes a valuable tool.
The best of 2019 – an A–Z of infectious diseases research
Take a look at the research highlights of 2019 as we count down the top infectious disease stories from A to Z!
WHO updates HIV testing recommendations
The WHO have updated their recommendations on HIV testing in order to try and expand treatment coverage and reach the people living with HIV who are not yet diagnosed.
Highlights of the Global Tuberculosis Report: more people receive treatment than ever before
In 2018 more people received treatment for tuberculosis than ever before, largely due to improvements in detection and diagnosis, according to the latest Global Tuberculosis Report from the WHO.
US FDA warns of serious liver injury linked to hepatitis C drugs: September’s industry headlines
Take a look at this month’s industry headlines including FDA warnings over hepatitis C drugs in patients with liver injury, a new infectious diseases strategy for the UK and priority review for Merck’s Ebola vaccine.
Novel blood test for tuberculosis could also identify high risk of infection
A novel phage-based blood assay has demonstrated its potential for identifying people at high-risk of developing tuberculosis, in addition to diagnosing established cases.
